Parashos S A, Barone P, Marin C A, Paraschos A J, Kapitzoglou-Logothetis V, Chase T N
National Institute of Neurological and Communicative Disorders and Stroke, Department of Health and Human Services, US Public Health Service, Bethesda, MD 20892.
Psychopharmacology (Berl). 1989;98(2):189-92. doi: 10.1007/BF00444690.
The effect of chronic D-1 and/or D-2 dopamine receptor blockade on apomorphine-induced behaviors was studied in rats treated for 21 days with the selective D-1 antagonist SCH23390, the predominantly D-2 antagonist haloperidol, and the combination of the two drugs at the same daily doses (0.1 and 1 mg/kg respectively). Apomorphine (0.3 mg/kg) 4 days following the last injection of the drugs increased (49-70%) stereotypic behavior in all animals as compared to saline-treated controls. Although the SCH23390-induced increase was lower than haloperidol-induced supersensitivity, stereotypies after combined administration of both drugs did not differ significantly from either, suggesting that the effects of the two drugs are not additive. Underlying receptor changes and modified D-1/D-2 receptor interactions may account for the participation of both receptor subtypes to the development of neuroleptic-induced dopaminergic supersensitivity.
在分别用选择性D-1拮抗剂SCH23390、主要的D-2拮抗剂氟哌啶醇以及以相同日剂量(分别为0.1和1mg/kg)联合使用这两种药物治疗21天的大鼠中,研究了慢性D-1和/或D-2多巴胺受体阻断对阿扑吗啡诱导行为的影响。在最后一次注射药物4天后,与生理盐水处理的对照组相比,阿扑吗啡(0.3mg/kg)使所有动物的刻板行为增加(49 - 70%)。虽然SCH23390诱导的增加低于氟哌啶醇诱导的超敏反应,但两种药物联合给药后的刻板行为与单独使用任一药物后的刻板行为相比无显著差异,这表明两种药物的作用不是相加的。潜在的受体变化和改变的D-1/D-2受体相互作用可能解释了两种受体亚型在抗精神病药物诱导的多巴胺能超敏反应发展中的参与。